Patents by Inventor James Bradley Breitmeyer

James Bradley Breitmeyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES OF INDOLINONE COMPOUNDS
    Publication number: 20220362211
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Application
    Filed: March 28, 2022
    Publication date: November 17, 2022
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • Uses of indolinone compounds
    Patent number: 11285132
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: March 29, 2022
    Assignee: Oncternal Therapeutics, Inc.
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • USES OF INDOLINONE COMPOUNDS
    Publication number: 20200253927
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Application
    Filed: April 13, 2020
    Publication date: August 13, 2020
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • Uses of indolinone compounds
    Patent number: 10646470
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: May 12, 2020
    Assignee: Oncternal Therapeutics, Inc.
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • Reduced dose intravenous acetaminophen
    Patent number: 10383834
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: August 20, 2019
    Assignee: Mallinckrodt Hospital Products IP Limited
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • USES OF INDOLINONE COMPOUNDS
    Publication number: 20190022062
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Application
    Filed: August 27, 2018
    Publication date: January 24, 2019
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • Uses of indolinone compounds
    Patent number: 10159660
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: December 25, 2018
    Assignee: Oncternal Therapeutics, Inc.
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • REDUCED DOSE INTRAVENOUS ACETAMINOPHEN
    Publication number: 20180256523
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • Reduced dose intravenous acetaminophen
    Patent number: 9987238
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: June 5, 2018
    Assignee: MALLINCKRODT IP
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • USES OF INDOLINONE COMPOUNDS
    Publication number: 20180028495
    Abstract: Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
    Type: Application
    Filed: July 26, 2017
    Publication date: February 1, 2018
    Inventors: Brian Lannutti, Katayoun Jessen, James Bradley Breitmeyer
  • REDUCED DOSE INTRAVENOUS ACETAMINOPHEN
    Publication number: 20170157071
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Application
    Filed: February 17, 2017
    Publication date: June 8, 2017
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • Reduced dose intravenous acetaminophen
    Patent number: 9610265
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: April 4, 2017
    Assignee: MALLINCKRODT IP
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • REDUCED DOSE INTRAVENOUS ACETAMINOPHEN
    Publication number: 20160287538
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 6, 2016
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • Reduced dose intravenous acetaminophen
    Patent number: 9399012
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: July 26, 2016
    Assignee: MALLINCKRODT IP
    Inventors: Mike Allan Royal, James Bradley Breitmeyer
  • REDUCED DOSE INTRAVENOUS ACETAMINOPHEN
    Publication number: 20090143474
    Abstract: Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
    Type: Application
    Filed: November 13, 2008
    Publication date: June 4, 2009
    Applicant: CADENCE PHARMACEUTICALS, INC.
    Inventors: Mike Allan Royal, James Bradley Breitmeyer